Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2021 09:25 ET | Source: H2 Clipper, Inc.

H2 Clipper Granted U.S. Patent for “Lighter-Than-Air” Dirigible Design, Advancing the Company’s Mission to Accelerate the Hydrogen Economy

SANTA BARBARA, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- H2 Clipper, Inc., an aerospace and alternative energy company developing uniquely capable hydrogen-powered dirigibles, announces that it was...
September 30, 2021 08:30 ET | Source: 180 Life Sciences Corp.

180 Life Sciences Corp. Continues To Expand Intellectual Property Portfolio

PALO ALTO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development...
September 29, 2021 08:00 ET | Source: OM HOLDINGS INTERNATIONAL, INC.

(OMHI) - OM Holdings International Inc. Announces Filing of Patent Application for Generating an On-Demand Provider Risk/Performance Score Using AI and Blockchain Technology

OMHI plans to Launch its On-Demand App in up to 28 Caribbean Countries Within the Next 5 Years Focusing on the $4.6B Food Delivery and Taxi MarketAI-Based Risk Score Intended to Ensure On-Demand...
September 28, 2021 10:00 ET | Source: LIDDS AB

LIDDS patent covering the NanoZolid® production process granted in Russia and Australia

UPPSALA, SWEDEN – LIDDS AB (publ) announces today that its most recent patent family on the NanoZolid® production process, and hence achieved pharmaceutical products, has been granted in Russia...
September 28, 2021 10:00 ET | Source: Orbus Therapeutics, Inc.

Orbus Therapeutics Granted European Patent for Method of Use for Eflornithine

- Patent relates to method for use of eflornithine to treat cancers, including gliomas - PALO ALTO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Orbus Therapeutics Inc., a private, late-stage...
September 27, 2021 08:41 ET | Source: Saint Jean Carbon

Saint Jean Carbon Provides Update on Solid Ultrabattery Facility

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Saint Jean Carbon Inc. (“Saint Jean” or the...
September 27, 2021 08:00 ET | Source: BetterLife Pharma Inc.

BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders

VANCOUVER, British Columbia, Sept. 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
September 27, 2021 07:00 ET | Source: PyroGenesis Canada Inc.

PyroGenesis Receives New U.S. Patent for the Destruction of Ozone Depleting Substances

MONTREAL, Sept. 27, 2021 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (NASDAQ: PYR) (TSX: PYR) (FRA: 8PY), a high-tech Company (hereinafter referred to as the “Company” or...
September 23, 2021 09:00 ET | Source: Gevo, Inc.

Gevo Acquires Butamax Patent Estate

ENGLEWOOD, Colo., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) is pleased to announce that it has entered into an asset purchase agreement, dated September 21, 2021, with Butamax...
September 22, 2021 07:30 ET | Source: Mydecine Innovations Group Inc.

Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

DENVER, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”), a biopharmaceutical company focused on the treatment of mental...